rp 73401 has been researched along with Trypanosomiasis, African in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ashton, TD; Bland, ND; Campbell, RK; Cotter, K; Fang, AP; Gangurde, R; Garceau, N; Gechijian, L; Gustafson, AE; McAllister, G; Ochiana, SO; Ondrechen, MJ; Ortenberg, R; Pollastri, MP; Tallman, C; Wang, C; Wang, Z | 1 |
| Bland, ND; Campbell, RK; Ochiana, SO; Pollastri, MP; Woodring, JL | 1 |
2 other study(ies) available for rp 73401 and Trypanosomiasis, African
| Article | Year |
|---|---|
Pharmacological validation of Trypanosoma brucei phosphodiesterases B1 and B2 as druggable targets for African sleeping sickness.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Benzamides; Catalytic Domain; Humans; Models, Molecular; Molecular Structure; Pyridines; Recombinant Proteins; Structure-Activity Relationship; Trypanocidal Agents; Trypanosoma brucei brucei; Trypanosomiasis, African | 2011 |
Synthesis and assessment of catechol diether compounds as inhibitors of trypanosomal phosphodiesterase B1 (TbrPDEB1).
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Benzamides; Catechols; Drug Discovery; Humans; Models, Molecular; Phosphodiesterase 4 Inhibitors; Protozoan Proteins; Pyridines; Trypanocidal Agents; Trypanosoma brucei brucei; Trypanosomiasis, African | 2013 |